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Abstract
Background: We have been investigating how interruption of differentiation contributes to the oncogenic process and the
possibility to reverse the transformed phenotype by restoring differentiation. In a previous report, we correlated the
capacity of intracellular Notch (ICN) to suppress v-Src-mediated transformation of quail neuroretina (QNR/v-src
ts) cells with
the acquisition by these undifferentiated cells of glial differentiation markers.
Methodology/Principal Findings: In this work, we have identified autocrine TGF-b3 signaling activation as a major effector
of Notch-induced phenotypic changes, sufficient to induce transition in differentiation markers expression, suppress
morphological transformation and significantly inhibit anchorage-independent growth. We also show that this signaling is
constitutive of and contributes to ex-vivo autonomous QNR cell differentiation and that its down-regulation is essential to
achieve v-Src-induced transformation.
Conclusions/Significance: These results support the possibility that Notch signaling induces differentiation and suppresses
transformation by a novel mechanism, involving secreted proteins. They also underline the importance of extracellular
signals in controlling the balance between normal and transformed phenotypes.
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Introduction
Differentiation is a multi-step process resulting from a cascade
of alternate activation and extinction of tissue-specific signaling
pathways. Progression through this cascade is generally mediated
by a sequence of extracellular signals, initiated by the differenti-
ating cells themselves or by their environment. As a consequence
of oncogenic events, this process is often interrupted and
differentiating cells can no longer exit the cell cycle. Hence,
blocking differentiation constitutes an important step in neoplastic
transformation. However, understanding its contribution can be
achieved only through the use of adequate experimental models.
The rationale for a differentiation therapy is based on the
assumption that cancer cells have retained the potential to respond
to appropriate differentiation signals, which in turn would be
sufficient to restore a normal phenotype. This could be achieved
either because the transformed cells undergo growth arrest or
because they no longer respond to oncogenic stimuli. Developing
models for the latter would be useful to identify pathways essential
for transformation and possibly result in new therapeutic
approaches. However, the task of reverting a cancer cell to its
normal state, in response to differentiation signals, has been only
reached in a very few clinical or experimental instances (for
review, [1]).
We previously reported that stable expression of Notch intra
cellular domain(ICN) suppresses transformation of embryonic quail
neuroretina (QNR) cells induced by a temperature sensitive v-Src
(QNR/v-src
ts), without altering oncoprotein expression nor its
downstream signaling activity. This remarkable phenotypic change
is correlated with a differentiation switch, as these undifferentiated
transformed cells acquire markers of glial cells [2]. Several reasons
support the choice of this ex-vivo model to study how activation of
differentiation signals could result in transformation suppression.
QNR cells dissected from 7-day old embryos progressively cease to
divide and autonomously execute glial and neuronal differentiation
programs [2–4]. As a consequence of v-Src activity, they acquire
sustained proliferative capacity [5,6], display all characteristics of
oncogenic transformation [7,8] and repress their autonomous
differentiation potential [2,9,10].
We have selected Notch as an instructive signal, because of its
important contribution to neuroretina development. At early
stages, it maintains progenitor cells in an undifferentiated state by
inhibiting their neuronal differentiation [11], whereas at later
stages it promotes glial differentiation [12,13]. We were also
interested in this signaling pathway because of its dual contribution
to either oncogenesis or tumor suppression, depending on the cell
model (for review, [14]). We also showed that both suppression of
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were mediated by its transcription factor partner, CBF [2].
Therefore, these results demonstrated that activating differentia-
tion signals was sufficient to abolish cell response to oncogenic
stimuli, thus lending further experimental basis to the differenti-
ation therapy concept.
Our previous work also indicated that interference of constitutive
Notch signaling with transformation possibly involved a secreted
factor(s). Culture medium from revertant cells, stably expressing the
Notch intracellular domain (QNR/v-src
ts/ICN) or an activated
human CBF (RBPJ-k), contains a paracrine activity which inhibits
transformation of QNR/v-src
ts cells [2]. This suggested that
secreted factors could play a key role at the cross-roads between
transformationand differentiation, in this cell system. Therefore, we
undertook to identify this activity and investigate its possible
autocrine effect on QNR cell transformation and differentiation.
In this report, we identified autocrine activation of TGF-b3
signaling as a major effector of the phenotypic changes induced by
ICN signaling, sufficient to suppress transformation of QNR/v-
src
ts cells and promote their acquisition of glial differentiation
markers, in presence of an active oncoprotein. We also show that
this signaling is activated during QNR cell ex-vivo differentiation
and that its down-regulation by v-Src is essential to block
differentiation and achieve transformation. Taken together, our
results provide a potentially novel mechanism by which Notch
signaling suppresses oncogenic transformation. They also under-
line the importance of extracellular signals in maintaining the
balance between the normal and transformed phenotypes.
Results
TGF-b3 mRNA is upregulated in QNR/v-src
ts cells stably
expressing ICN
To understand the mechanisms by which Notch signaling
activation suppressed cell transformation, we compared the
transcription profile of QNR cells transformed by a v-src mutant
encoding a temperature sensitive (ts) oncoprotein (QNR/v-src
ts),
withthatofcellsstablyexpressing ICN(QNR/v-src
ts/ICN).mRNA
were prepared from cells maintained at permissive (37uC) or
restrictive (41uC) temperature. For each temperature, cDNA from
QNR/v-src
ts cells wereprobed with that of QNR/v-src
ts/ICN cells,
on microarrays spotted with 13,000 cDNA from chicken EST
collections[15].Thisanalysisrevealed209genesdisplaying,atleast,
a 1.5 fold increase in QNR/v-src
ts/ICN, as compared to QNR/v-
src
ts cells. As we previously showed that suppression of QNR/v-src
ts
cell transformation possibly involved a secreted factor(s) [2], we
were primarily interested in genes encoding potentially secreted
proteins. Among 18 such genes, we identified, as a most highly
induced one, the gene encoding the TGF-b3 ligand, the expression
of which was increased 8 to 16 times in QNR/v-src
ts/ICN cells. We
focused our study on this protein, because of its important role
during oncogenesis (for review, [16]).
Gene array results were validated by QPCR experiments. These
experiments showed a 13-time induction of normalized TGF-b3
mRNA levels in QNR/v-src
ts/ICN cells, compared to QNR/v-
src
ts cells at 37uC. At 41uC, TGF-b3 mRNA amounts were 10
times higher in QNR/v-src
ts/ICN cells than in QNR/v-src
ts cells,
at the same temperature (Fig. 1). However, in QNR/v-src
ts/ICN
cells, transcript levels were more elevated at 41uC than at 37uC. A
similar difference was observed in QNR/v-src
ts cells, suggesting
that TGF-b3 mRNA levels were regulated by v-Src activity.
Increased levels of TGF-b3 mRNA were also found in QNR/v-
src
ts cells stably expressing a constitutively activated human RBP-
Jk, indicating that this increase was mediated by the ICN/CBF
complex (data not shown). Therefore, it was likely that the
presence of higher TGF-b3 mRNA levels would lead to an
activation of TGF-b signaling in QNR/v-src
ts/ICN cells.
QNR/v-src
ts/ICN cells secrete and respond to mature
TGF-b3 activity
We first investigated whether mature TGF-b was secreted by
QNR/v-src
ts/ICN cells. Therefore, we collected cell-free medium
from these cells (ICN medium) maintained at 41uC (v-Src inactive)
and from cells transferred to 37uC (v-Src active) for 72 hours, and
examined its capacity to activate phosphorylation of the TGF-b
signaling effector Smad2 [17], in QNR/v-src
ts cells. Control
medium was obtained from transformed QNR/v-src
ts cells (v-Src
medium), maintained at either temperature. Phosphorylated
Smad2 was barely detectable in QNR/v-src
ts cells cultured at
37uC and was not increased when these cells were treated with
their own medium collected at either temperature (Fig. 2A), ruling
out both TGF-b signaling activation in transformed cells and
TGF-b release by these cells at detectable levels. In contrast,
incubating QNR/v-src
ts cells in ICN medium, collected at either
temperature, markedly increased the levels of phosphorylated
Smad2. Furthermore, in agreement with our comparative Q-PCR
results, medium collected at 41uC was significantly more efficient
in activating Smad2 phosphorylation (Fig. 2A).
To confirm that this increase in Smad2 phosphorylation was
due to TGF-b activity, we treated QNR/v-src
ts cells with ICN
medium in presence of the TGF-bRI kinase inhibitor, SB431542
[18], at concentrations ranging between 0.25 and 10 mM. We
observed a dose dependent reduction of Smad2 phosphorylation
in presence of the inhibitor (Fig. 2B).
Figure 1. TGF-b3 mRNA is upregulated in QNR/v-src
ts/ICN cells.
QNR/v-src
ts and QNR/v-src
ts/ICN cells were incubated 72 hrs at 37uCo r
41uC before extraction of total RNA. After reverse transcription of 1 mg
of RNA, TGF-b3 cDNA was amplified by QPCR using specific primers
(Table 1) Results were normalized based on HPRT and TBP transcript
levels and presented in relative arbitrary units. Normalized TGF-b3
mRNA levels detected in QNR/v-src
ts cells at 37uC were used as
reference equal to 1. Each bar represents the mean -/+ S.E. of
experiments realized on 3 different cultures per cell type.
doi:10.1371/journal.pone.0013572.g001
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Western blotting, the presence of a specific mature TGF-b3 band,
migrating at about 25 kDa, in ICN medium, collected at either
temperature (Fig. 2C). This band was present in higher amounts in
ICN medium collected at 41uC and was not found in v-Src
medium collected under either temperature condition. To confirm
the contribution of TGF-b3 to Smad2 phosphorylation, we
incubated QNR/v-src
ts cells with ICN medium, in the presence
of increasing amounts of TGF-b3 blocking antibody. In agreement
with SB431542 treatment, the levels of phosphorylated Smad2
were decreased as a function of antibody concentration (Fig. 2D),
indicating that Smad2 phosphorylation was essentially due to
secreted TGF-b3.
Finally, we examined the activation ofTGF-b signalingin QNR/
v-src
ts/ICN cellsby measuring endogenous Smad2 phosphorylation
in presence or absence of an active v-Src. Phosphorylated Smad2
was detected in QNR/v-src
ts/ICN cells at 37uC and at higher levels
at 41uC (Fig. 2E). In both cases, the presence of phosphorylated
Smad2 was sensitive to that of the SB431542 inhibitor (Fig. 2E),
indicating that activation of TGF-b signaling resulted from an
autocrine response of these cells to mature TGF-b3 activity.
TGF-b signaling was previously shown to directly regulate
TGF-b3 transcription [19]. Therefore, we examined whether
activation of this pathway in QNR/v-Src
ts/ICN cells could be
associated with an auto-regulation of TGF-b3 expression. We
found that treatment of QNR/v-Src
ts cells with recombinant
TGF-b3 induced an increase of TGF-b3 mRNA levels (Fig. 3A).
Conversely, inhibition of TGF-b signaling in QNR/v-Src
ts/ICN
cells resulted in a decrease of TGF-b3 mRNA amounts (Fig. 3B).
Therefore, it appears that TGF-b3 mRNA induction results in
both mature TGF-b3 secretion and autocrine signaling activation,
which in turn initiates a positive feed-back control maintaining the
levels of TGF-b3 mRNA in QNR/v-src
ts/ICN cells.
TGF-b signaling suppresses v-Src-induced morphological
transformation by restoring cytoskeleton organization
To determine whether suppression of morphological transfor-
mation was due to TGF-b3 activity, we examined the effects of
recombinant TGF-b3 on cell morphology. QNR/v-src
ts cultures,
maintained at 37uC, are typically composed of refractile round or
fusiform transformed cells. Their morphology was markedly
changed within 24 hours, following treatment with 1–10 ng/ml of
recombinant TGF-b3 (Fig. 4 a–c). Cells became flat, transparent
with a polygonal, epithelial like morphology. The extent of these
changes reflected a major cytoskeleton reorganization. Transfor-
mation of QNR/v-src
ts cells is defined by the loss of actin stress
fibers (Fig. 4 d). In contrast, the cytoskeleton of TGF-b3 treated cells
became well organized, with abundant stress fibers (Fig. 4 e, f).
QNR/v-src
ts/ICN cells maintained at 41uC exhibit a normal
morphology. When transferred to 37uC, they retain an organized
cytoskeleton underlined by the presence of numerous stress fibers
[2]. We investigated whether autocrine TGF-b signaling was
responsible for maintaining their normal morphology, in presence
of an active oncoprotein. Treatment of these cells with increasing
concentrations of SB431542 induced morphological changes,
including a marked increase in the number of refractile cells
extending processes (Fig. 5 a–e). Actin fibers became thinner and
Figure 2. QNR/v-src
ts/ICN cells secrete and respond to mature
TGF-b3. (A) Media were collected after a 30-hour incubation of QNR/v-
src
ts (v-src
ts medium) and QNR/v-src
ts/ICN (ICN medium) cells at 37uCo r
41uC. QNR/v-src
ts cells were incubated at 37uC in normal medium (BME)
or conditioned media for 1 hour, before lysis. Phosphorylated Smad2
was detected by western-blot. b–actin was used for protein level
normalization. (B) QNR/v-src
ts cells were treated at 37uC with increasing
concentrations of SB431542 inhibitor for 2 hrs and then incubated in
ICN medium during 1 hour in presence of inhibitor. Effects of this
treatment on Smad2 phosphorylation were analyzed by western-blot.
(C) Comparison of mature TGF-b3 levels in v-Src and ICN media. Cells
were plated at 2.10
6 cells per 100 mm dish at 37uCo r4 1 uC. One day
after plating, growth media were replaced with serum-free BME. After a
30-hour incubation, media were collected and concentrated 50 times
using Vivaspin6 columns. 20 mg of proteins were migrated under non-
denaturing conditions. Mature TGF-b3 migrates as 25 kDa band. (D)
QNR/v-src
ts cells were treated, one hour before lysis, with ICN medium
preincubated at 37uC for one hour with increasing amounts of
neutralizing antibodies directed against TGF-b3. Levels of Smad2
phosphorylation were analyzed by western-blot. Erk was used to
normalize protein loading. (E) Levels of phosphorylated Smad2 in QNR/
v-src
ts/ICN cells treated at 37uCo r4 1 uC with DMSO or 10 mMo f
SB431542 inhibitor for 24 hrs.
doi:10.1371/journal.pone.0013572.g002
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detected in control cells treated with DMSO (Fig. 5 f, g). Similar
treatment of QNR/v-src
ts cells had no detectable effect on their
morphology (data not shown). These results indicated a dominant
interference of TGF-b signaling with cytoskeleton organization, to
restore a normal cell morphology.
TGF-b signaling suppresses morphological
transformation by increasing a2-actin expression and
Myosin Light Chain phosphorylation
TGF-b activity was previously shown to interact with signaling
pathways targeting cytoskeleton components (for review [20]).
Accordingly, our comparative RNA analysis showed a 25-fold
increase of a2-actin mRNA in QNR/v-src
ts cells stably expressing
ICN, as compared to v-Src-transformed cells. This was validated
by QPCR (Fig. 6A), suggesting that TGF-b signaling contributes
to cytoskeleton restoration, in part by increasing the abundance of
a-actin fibers. Moreover, treatment of QNR/v-src
ts cells with
recombinant TGF-b3 significantly increased the levels of a2-actin
mRNA, as determined by QPCR (Fig. 6B). Conversely, treatment
of QNR/v-src
ts/ICN cells with SB431542 resulted in a decreased
a2-actin expression (Fig. 6C), indicating a significant contribution
of TGF-b signaling in regulating the levels of this mRNA in ICN
containing cells.
We previously correlated suppression of morphological trans-
formation, in QNR/v-src
ts/ICN cells, with an increase of Myosin
Light Chain (MLC) phosphorylation, as compared to v-Src
transformed cells [2]. To assess the contribution of TGF-b
signaling to this phosphorylation, we treated QNR/v-src
ts cells
with increasing doses of recombinant TGF-b3. This treatment
increased the levels of MLC phosphorylation in QNR/v-src
ts cells,
as compared to untreated cells (Fig. 6D).
Taken together, these results indicate that TGF-b signaling
contributes to cytoskeleton reorganization both by increasing
expression of a2-actin and favoring its polymerization into stress
fibers by inducing MLC phosphorylation [21].
Autocrine TGF-b signaling contributes to anchorage-
independent growth inhibition of QNR/v-src
ts/ICN cells
In addition to morphological transformation, v-Src transformed
QNR cells display anchorage-independent growth capacity [8], a
characteristic marker of ex-vivo oncogenic transformation. QNR/v-
src
ts cells efficiently give rise to colonies in soft agar containing
medium, whereas QNR/v-src
ts/ICN cells fail to divide under the
same conditions. Moreover, treatment of QNR/v-src
ts cells with
ICN medium also inhibits their anchorage-independent growth
capacity [2]. We investigated whether autocrine TGF-b activity
was also responsible for the loss of anchorage-independent growth
by QNR/v-src
ts/ICN cells. Therefore, we tested their capacity to
form colonies in soft agar containing medium, in presence or
absence of the SB431542 inhibitor. We found that while untreated
cells could not give rise to colonies, their anchorage-independent
growth capacity was restored when TGF-b signaling was inhibited.
However, this restoration was only partial, as the number and size
of colonies were smaller than those observed in QNR/v-src
ts cells
(Fig. 7).
Therefore, activation of autocrine TGF-b signaling, following
ICN stable expression, is predominantly responsible for suppress-
ing v-Src-induced transformation of QNR cells, as defined by the
loss of both morphological transformation and anchorage-
independent growth capacity.
TGF-b3 signaling is required to induce and maintain
expression of glial markers in QNR/v-src
ts/ICN cells
WepreviouslyshowedthatprimarydissociatedQNRculturesare
composed of a mixture of progenitor and differentiated cells.
Accordingly, they contain neuronal and glial markers, indicating
that they can autonomously proceed into differentiation (32). As a
result of transformation, this process is interrupted, as the vast
majority of QNR/v-src
ts cells express only the marker combination
of progenitor cells. In QNR/v-src
ts/ICN cells, the loss of precursor
cell markers was combined with the acquisition of neuroretina glial
cell markers, indicating a switch in differentiation program (32).
To determine the contribution of TGF-b signaling to these
changes, we treated QNR/v-src
ts cells with recombinant TGF-b3
Figure 3. TGF-b3 expression is controlled by a positive feed-
back loop. QPCR analysis of TGF-b-3 mRNA levels in (A) QNR/v-src
ts
treated with 2 mg/ml of recombinant TGF-b3 or (B) QNR/v-Src
ts/ICN cells
at 37uC incubated with increasing doses of SB431542 during 24 hrs.
After reverse transcription of 1 mg of RNA, TGF-b3 cDNA were amplified
by QPCR. Results were normalized based on HPRT and TBP transcript
levels and presented in relative arbitrary units using values obtained for
untreated cells as reference equal to 1. Each bar represents the mean
2/+ S.E. of three experiments.
doi:10.1371/journal.pone.0013572.g003
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predominantly present in progenitor and transformed cells [2] and
glutamine synthetase (GS), a marker of mature glial cells [22]. We
observed a marked decrease of Pax6 protein levels together with an
induction of GS expression, in treated cells (Fig. 8A). Thus, activation
of TGF-b signaling is sufficient to inverse the balance of
differentiation markers in QNR/v-src
ts cells and recapitulates the
opposite evolution of Pax6 and GS markers, as observed both during
QNR cell differentiation and in QNR/v-src
ts/ICN cells [22,23].
We next examined whether autocrine TGF-b signaling was
responsible for inducing and maintaining glial like differentiation
of QNR/v-src
ts/ICN cells. Therefore, we treated these cells with
SB431542, once ICN stable expression was achieved, and
examined whether they could be induced to reexpress Pax6. We
found that while the number of nuclear Pax6 positive cells was
initially low in these cultures, the proportion of cells containing this
marker markedly increased, following TGF-b signaling inhibition
(Fig. 8B). Conversely, GS expression was suppressed in treated
cells (data not shown). These results indicate that autocrine
activation of TGF-b signaling, as a consequence of ICN stable
expression, is effective in upsetting the balance of markers
expression in QNR/v-Src
ts cells.
Figure 4. Recombinant TGF-b3 suppresses morphological transformation and induces cytoskeleton reorganization. QNR/v-src
ts cells
were incubated at 37uC in absence or presence of 1 or 10 ng/ml of recombinant TGF-b3 protein. 24 hrs later, cells were fixed and F-actin stress fibers
labeled with FITC-phalloı ¨din. Magnification: x20 for phase-contrast morphology (a–c); x40 for F-actin staining (d–f).
doi:10.1371/journal.pone.0013572.g004
Figure 5. Inhibition of TGF-b signaling disrupts cell morphology and cytoskeleton organization of QNR/v-Src
ts/ICN cells. QNR/v-Src
ts/
ICN cells were incubated at 37uC in presence of DMSO (control) or increasing (1–50 mM) concentrations of SB4314542. SB431542 treatment induces
retraction of cells but no toxicity even at high doses. 3 days later, cells were fixed and F-actin stress fibers were labeled with FITC-phalloı ¨din.
Magnification: x20 for morphology (a–e); x40 for F-actin staining (f–j).
doi:10.1371/journal.pone.0013572.g005
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differentiation
We then examined whether TGF-b3 activation in QNR/v-src
ts/
ICN cells was merely due to ectopic ICN expression or whether it
belonged to restoration of the QNR ex-vivo differentiation program,
as a consequence of Notch signaling. Therefore, we investigated the
presence of TGF-b3 mRNA in QNR cells dissected from 7 day-old
embryos (E7) and cultured for various time lengths. As mentioned
above, these cells undergo an intrinsic differentiation program
defined by the progressive loss of precursor cell markers and the
acquisition of glial and neuronal cell markers [2–4]. We found that,
Figure 6. TGF-b signaling induces a2-actin expression and
MLC2 phosphorylation. QPCR analysis of a2-actin mRNA levels in (A)
QNR/v-src
ts and QNR/v-src
ts/ICN cells at 37uC and 41uC, (B) QNR/v-src
ts
cells treated at 37uC for 24 hrs with increasing concentrations (0.5–
2 ng/ml) of recombinant TGF-b3 protein, or (C) QNR/v-src
ts/ICN treated
at 37uC for 24 hrs with increasing concentrations of SB431452 (1–
50 mM) Results are represented in relative arbitrary units after
normalization using HPRT and TBP transcript levels. For (A), data
presented are representative of three distinct experiments. For (B and
C), each bar represents the mean 2/+ S.E. of three experiments. (D)
QNR/v-src
ts cells were treated with increasing doses of recombinant
TGF-b3 protein for 24 hrs. One hour before lysis, TGF-b3 treatment was
renewed. Phosphorylated MLC2 was detected by western-blot and Erk
levels were used for normalization.
doi:10.1371/journal.pone.0013572.g006
Figure 7. Inhibition of TGF-b signaling restores anchorage-
independent growth of QNR/v-Src
ts/ICN cells. QNR/v-Src
ts/ICN
cells were incubated without or with 2 mM of SB431542 for 24 hrs and
subsequently seeded in soft agar containing medium, in absence or
presence of SB431542. Treatment with the inhibitor was renewed every
second day during 2 weeks. Pictures of colonies were taken 15 days
later. Magnification x20.
doi:10.1371/journal.pone.0013572.g007
ICN and TGF-b Cooperation
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precursor cells one day after dissection (E7+1), its level progressively
increased between 8 (E7+8) and 18 (E7+18) days, thereafter
(Fig. 9A). These (E7+18) long term cultures essentially contain cells
expressing only markers of glial differentiation (Fig. 9C). This
indicated that steady state levels of TGF-b3 mRNA autonomously
increase in cultured QNR cells and that this increasing parallels the
course of their ex-vivo differentiation.
v-Src-mediated transformation correlates with inhibition
of ex-vivo differentiation and TGF-b3 down-regulation
Results described above indicated that TGF-b3e x p r e s s i o nw a s
down-regulated in both QNR progenitors and undifferentiated
transformed QNR/v-Src
ts cells. The latter may simply reflect the
possibility that precursor cells constitute a preferential target for v-
Src-induced transformation and are subsequently maintained in their
undifferentiated state, as a consequence of their sustained division. To
determine whether v-Src activity would affect differentiation markers
and TGF-b3 expression once established, we infected (E7+18) QNR
cells, with RSVts68 and selected for transformed cells by passaging.
WhilePax6,amarkerofprecursorQNRcells,wasnolongerdetected
in (E7+18) uninfected cells (Fig. 9B a), the great majority of
transformed cells reexpressed Pax6(Fig. 9B b). In turn, the number of
Pax6 positive cells progressively declined between 7 and 15 days,
following v-Src thermal inactivation (Fig. 9B c,d), as observed during
intrinsic ex-vivo differentiation (data not shown). Conversely, the GS
glial marker, present in (E7+18) QNR cells, was no longer found in
transformed cells, but became again detectable following v-Src
inactivation (Fig. 9C).
We also found that the level of TGF-b3 mRNA was markedly
r e d u c e di nt r a n s f o r m e dc e l l s ,a sc o m p a r e dt ot h a to fu n i n f e c t e dc e l l s
(Fig. 9D), and progressively resumed following v-Src inactivation at
41uC (Fig. 9E). To determine the contribution of TGF-b signaling in
regulating expression of these two markers, we treated (E7+18) QNR
transformed cells with SB431542, prior to their transfer to the non-
permissive temperature and maintained TGF-b signaling inhibition
during 15 days. This resulted in delaying the autonomous down-
regulation of Pax6 (Fig. 9B, e–g) and reexpression of GS (Fig. 9C).
Taken together, these results indicate that v-Src-mediated
transformation of QNR cells, already displaying characteristics
of glial cells, leads to repression of the GS marker and,
interestingly, to the reemergence of undifferentiated cells express-
ing the Pax6 precursor marker. Conversely, oncoprotein inactiva-
tion allows these cells to resume their autonomous differentiation.
Moreover, concomitant down-regulation of TGF-b3 expression
appears to be strictly correlated with transformation of QNR cells
and partially mediate the differentiation block. Therefore,
concomitant arrest of differentiation and down-regulation of
TGF-b3 appear essential to achieve transformation of QNR/v-
src
ts cells. Finally, they suggest that TGF-b3 expression, which is
restored in QNR/v-src
ts/ICN cells, is constitutive of and effects
their switch toward glial like cells.
Discussion
We have been investigating how blocking differentiation
contributes to the oncogenic transformation of neural cells and
the possibility to activate instructive signals, as a mean to reverse
the oncogenic process. In this work, we reported that v-Src-
Figure 8. TGF-b signaling controls commitment into glial differentiation. (A) QNR/v-src
ts cells were treated at 37uC with increasing
concentrations (0.2–2 ng/ml) of recombinant TGF-b 3 protein during 7 days. Pax6 and Glutamine Synthetase (GS) were detected by western-blot.
Protein loading was normalized using Erk antiserum. (B) Pax6 expression was analyzed by immunofluorescence after treatment of QNR/v-Src
ts/ICN
cells at 37uC with DMSO (control) or 10 mM SB431542 during 7 days. The majority of control QNR/v-Src
ts/ICN cells did not express nuclear Pax6 but we
observed a weak peri-nuclear labeling. Magnification x40.
doi:10.1371/journal.pone.0013572.g008
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PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13572Figure 9. Inhibition of QNR cell differentiation correlates with TGF-b3 down-regulation by v-Src. (A) QPCR analysis of TGF-b3 mRNA
levels in 7-day-old (E7) embryonic QNR seeded for 1 (E7+1), 8 (E7+8) or 18 (E7+18) days. Results were normalized based on HPRT and TBP transcript
levels and presented in relative arbitrary units, using values obtained for E7+1 QNR cells as reference. (B) Detection of Pax6 expression by
immunofluorescence in QNR (E7+18) (a) and QNR(E7+18)/v-src
ts cells, maintained at 37uC (b-e) or transferred to 41uC for 7 (c–f) and 15 days (d–g), in
presence of DMSO (control) or 10 mM SB431542. At 41uC (c–d), nuclear Pax6 expression progressively decreased in control cells, but we reproducibly
observed an unusual Pax6 peri-nuclear labeling. Insets represent DAPI staining. Magnification x40 (C) Expression of Glutamine synthetase (GS) in QNR
(E7+18) and QNR (E7+18)/v-src
ts cells at 37uC or following their transfer to 41uC for 7 and 15 days, in presence of DMSO (c) or 10 mM of SB431542 (SB)
Erk was used to normalize protein loading. (D) TGF-b3 mRNA levels were analyzed by QPCR in uninfected (N.I) QNR (E7+18) cells or in QNR (E7+18)/v-
src
ts cells at 37uC. (E) TGF-b3 mRNA levels in QNR(E7+18)/v-src
ts cells at 37uC or transferred to 41uC for 7 and 15 days. Values are represented in
relative arbitrary units after HPRT and TBP normalization.
doi:10.1371/journal.pone.0013572.g009
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interruption of differentiation and maintenance of transformed cells
in an undifferentiated state. In addition, transformation can be
suppressed by restoring endogenous signaling pathways involved in
determining cell identity. We identified autocrine activation of TGF-
b3 signaling as a key effector of ICN-mediated switch in expression of
differentiation markers and suppression of transformation.
Ex-vivo differentiating QNR cells undergo phenotypic changes
that reflect the execution of an intrinsic program, characterized by
the progressive loss of precursor cell markers (e.g. Pax6) and the
acquisition of neuronal and glial differentiation markers [2–4].
Long term cultures become essentially composed of flat epithelial
like cells, expressing only markers of glial differentiation (e.g. GS
and vimentin). We showed that a marked increase in TGF-b3
mRNA steady state levels is part of this autonomous process and
partially contributes to its execution. However, these quiescent
QNR cultures display remarkable plasticity, as they can be
transformed by v-Src, reenter the cell cycle and reexpress Pax6.
Upon v-Src
ts thermal inactivation, their capacity to differentiate is
again restored. Switching up and down the ratio of Pax6 to GS
markers, depending on v-Src activity, correlates with down or up-
regulation of TGF-b3 expression. Thus, in this cell system,
concomitant down-regulation of differentiation markers and TGF-
b3 expression proved essential for v-Src-induced transformation.
Similar down-regulation of TGF-b3 transcription was reported in
v-Src transformed chicken fibroblasts, without further assessment
of its contribution to transformation [24]. The mechanisms
leading to TGF-b3 down-regulation, as a consequence of v-Src
activity, are presently unknown. This contrasts with other cell
systems, where v-Src was shown instead to activate TGF-b1
transcription essentially through AP1 sites on its promoter [25]
and with reports showing increased TGF-b activity in oncogene
transformed cells [26,27].
In contrast with v-Src-transformed cells, TGF-b3 mRNA is up-
regulated in QNR/v-src
ts/ICN cells, once ICN stable expression is
established, and is maintained through multiple cell passaging
despite the presence of an active oncoprotein. Our results indicate
that TGF-b3 expression is regulated at multiple levels. First, TGF-
b3 mRNA level in QNR/v-src
ts/ICN cells remains partially under
v-Src control, as it is significantly higher when the oncoprotein is
inactive. This suggests the existence of a dominant negative
interference of Notch signaling with v-Src-dependent TGF-b3
down-regulation. Second, increased TGF-b3 expression also
appears to be a consequence of Notch signaling per se, as its
mRNA is maintained at a significantly higher level in QNR/v-
src
ts/ICN as compared to QNR/v-src
ts cells, when v-Src
ts is
thermally inactivated and Notch signaling is acting alone.
However, we found that TGF-b3 mRNA levels were not
significantly diminished when ICN expression was down-regulated
by specific siRNA, in QNR/v-Src
ts/ICN cells. Similarly, forced
ICN expression in QNR/v-Src
ts cells did not increase these levels
in transient transfection assays (data not shown). Therefore, TGF-
b3 mRNA up-regulation in QNR/v-Src
ts/ICN cells is not a direct
consequence of ICN expression but is likely to belong to the
restoration of their autonomous differentiation program, as
observed in normal QNR cells, and is subsequently maintained
through a positive feed-back control. Although the mechanism
involved in TGF-b3 mRNA up-regulation remains undefined, our
work provides the first example of Notch and TGF-b signaling
cooperation in suppressing transformation.
Mature TGF-b3 is secreted by QNR/v-src
ts/ICN cells and
initiates an autocrine loop to activate endogenous TGF-b
signaling. Analyzing how this signaling contributes to the
phenotypic changes induced by ICN, we have established a strong
correlation between its capacity to suppress transformation and
induce the switch in differentiation markers. Thus, treatment of
precursor like QNR/v-src
ts cells with recombinant TGF-b3i s
sufficient to convert them into glial like cells, by down-regulating
expression of Pax6 and inducing that of GS. This is concomitant
with the loss of their transformed phenotype. Our data also point
to a major role of TGF-b signaling in the control of cell
morphology and cytoskeleton organization, as also reported in
other cell systems (for review [20]). Maintaining normal cell
morphology may also be essential for differentiation. This is
supported by previous data showing that cytoskeleton depolymer-
ization inhibits expression of the GS marker of Mu ¨ller cell
differentiation [28]. Thus, TGF-b signaling would control
differentiation by acting both on cell markers expression and
cytoskeleton organization. Therefore, it appears that the majority
of the phenotypic changes, induced by ICN stable expression, are
achieved by restoring endogenous TGF-b signaling, repressed as a
consequence of v-Src activity.
Both Notch and TGF-b signaling play a dual role in
oncogenesis, depending on the cell context (for review [14,29].
Notch activation contributes to oncogenesis by promoting survival
or proliferation of undifferentiated precursor cells. The role of
TGF-b signaling is more complex and impacts on various steps of
tumor progression (for review [16,30]. When acting as tumor
suppressors, both pathways promote growth arrest by upregulating
expression of the cyclin/CDK inhibitor p21
cip1/waf1, which in turn
favors differentiation [31,32]. Our results indicate that suppression
of QNR/v-src
ts cell transformation by the conjunction of both
signaling pathways involves distinct mechanisms, in various
aspects. First, in this cell system, QNR/v-src
ts cells reversion to
a normal phenotype, in presence of an active v-Src, is compatible
with their sustained division. Moreover, ICN stable expression
confers extended growth capacity upon QNR/v-src
ts/ICN cells
when v-Src
ts is thermally inactivated, whereas QNR/v-src
ts cells
stop dividing under these non permissive conditions (32). This
strongly suggests that, while QNR/v-src
ts/ICN cells have acquired
glial specific markers, they are not mature glial cells, as their
terminal differentiation would normally require extinction of
Notch signaling [33,34]. Second, we also reported a strong
cytoplasmic accumulation of p21
cip1/waf1 in dividing QNR/v-
src
ts/ICN cells, suggesting for this protein a role distinct from that
of a cell cycle inhibitor [2]. Third, all these phenotypic changes
take place in presence of an active oncoprotein, in contrast to
other models where oncogene inactivation is required for
differentiation [35–37].
Tumor cells generally do not respond to extracellular signals
that normally control their growth or differentiation [38]. A likely
reason would be that they down-regulate expression of genes
encoding such secreted proteins or their receptors. Alternatively,
proteins secreted by tumor cells could be endowed with pleiotropic
properties and instead favor tumor progression, as described with
TGF-b signaling (for review [16,39]. However, it was also shown
that certain tumor cells display remarkable plasticity when placed
in appropriate environments (for review, [40,41]. Therefore,
analyzing the response of tumor cells to extracellular signals,
potentially capable of modulating the transformed phenotype is
required to understand crucial events in transformation and
develop specific therapeutic approaches.
Materials and Methods
Reagents
The TGF-b type I receptor kinase inhibitor, SB431542 was
purchased from Sigma (Sigma-Aldrich, Lyon, France) and
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protein (243-B3) and TGF-b3 monoclonal antibody (MAB243)
were purchased from R&D systems (Minneapolis, MN, USA).
Cell cultures and virus
QNR were dissected from 7-day-old Japanese quail embryos
(Cailles de Chanteloup, Corps-Nuds, France) and cultured in Basal
Medium Eagle (BME) supplemented with 8% fetal calf serum
(Biowest, Nuaille ´, France), as described (Pessac et al., 1983). QNR
cells were infected with Rous Sarcoma Virus tsNY68 encoding a
thermolabile mutant of v-Src. Isolation and properties of RSV
tsNY68 mutant were reported previously (Kawai and Hanafusa,
1971). QNR/v-src
ts/ICN were obtained as previously described [2].
Preparation of cell-conditioned media
QNR/v-src
ts and QNR/v-src
ts/ICN cells (2.10
6 cells/100 mm
dish) were cultured in serum-free BME. Serum-free media were
collected after 30 hours and filtered. When necessary, collected
supernatants were supplemented with 8% FCS.
Anchorage-independent growth
Colony formation in soft agar was assessed as previously
described [2]. For paracrine activity assays, cell-free culture
supernatants were diluted 1:2 with BME and supplemented with
DMSO or 2 mM of SB431542. Every second day, media were
renewed in presence of DMSO or 2 mM of SB431542. Colonies
were observed 10–15 days later.
RNA preparation and Microarray RT-PCR analysis
Total RNA was prepared using the RNeasy extraction kit
(Qiagen, Courtaboeuf, France). 1 mg of total RNA was reverse-
transcribed into cDNA using Superscript II reverse transcriptase
(Invitrogen SARL, Cergy-Pontoise, France). Quantitative real-
time PCR (QPCR) analyses were performed with iQ SYBR Green
supermix (Bio-Rad, Marnes-la-coquette, France). Primers used for
real-time QPCR were designed according to sequences in
GenBank (Table 1). Reactions were carried out in an iCycler
Thermal Cycler (Bio-Rad, Marnes-la-coquette, France) for 40
cycles (95uC for 15 sec, 60uC for 1 min) after an initial 10-min
incubation at 95uC. mRNA levels were normalized to the levels of
HPRT and TBP mRNA.
Formicroarrayanalysis,totalRNAwasanalyzedandprocessedby
the genomic facility of the Fred Hutchinson Cancer Research Center
(Seattle, WA, USA) using a 13,000 chicken microarray (http://www.
fhcrc.org/science/shared_resources/genomics/dna_array). Genes
were considered to be differentially regulated when the log2 ratio
between two conditions and in the dye swap experiments was
superior to0.58 correspondingto a variation of 1.5. Allthe gene array
data has been deposited in the GEO database (GSE22054).
Western blotting
Cell extracts preparation, protein analysis by SDS-PAGE and
western-blotting were performed as previously reported [2]. Blots
were probed with primary antibodies used at the following
dilutions: anti-phosphorylated Smad2 (Ser465/467; #3101) and
anti-phosphorylated MLC2 (Ser19; #367) polyclonal antibodies
(Cell Signaling Technology, Hertfordshire, UK) at 1/1000
e; anti-
TGF-b3 monoclonal antibody (MAB243; R&D systems, Minnea-
polis, MN, USA) at 1/500
e; anti-Glutamine Synthetase monoclo-
nal antibody (Chemicon, Hampshire, UK) at 1/1000
e; anti-Erk1
polyclonal antibody (SC-93, Santa-Cruz Biotechnology, Santa-
Cruz, CA, USA) at 1/2000
e; and anti b-actin monoclonal
antibody (Amersham Pharmacia Biotech, Piscataway, NJ, USA)
at 1/10000
e.
Immunofluorescence
Cells were fixed and treated as previously described [2]. Mouse
monoclonal anti-Pax6 antibody (kindly provided by S Saule) was
used at 1/10
e. Fluorescein isothiocyanate (FITC)-conjugated goat
anti-mouse immunoglobulin G (Sigma-Aldrich, Lyon, France) was
diluted at 1/200
e. F-actin fibers were labeled as described [2].
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